| Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation KS Soni, SS Desale, TK Bronich Journal of Controlled Release 240, 109-126, 2016 | 574 | 2016 |
| Targeted delivery of platinum-taxane combination therapy in ovarian cancer SS Desale, KS Soni, S Romanova, SM Cohen, TK Bronich Journal of Controlled Release 220, 651-659, 2015 | 64 | 2015 |
| Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models SS Desale, SM Raja, JO Kim, B Mohapatra, KS Soni, H Luan, SH Williams, ... Journal of controlled release 208, 59-66, 2015 | 45 | 2015 |
| Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition SM Raja, SS Desale, B Mohapatra, H Luan, K Soni, J Zhang, MA Storck, ... Oncotarget 7 (9), 10522, 2016 | 29 | 2016 |
| A polymeric nanogel-based treatment regimen for enhanced efficacy and sequential administration of synergistic drug combination in pancreatic cancer KS Soni, D Thomas, T Caffrey, K Mehla, F Lei, KA O’Connell, S Sagar, ... Journal of Pharmacology and Experimental Therapeutics 370 (3), 894-901, 2019 | 18 | 2019 |
| Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer KS Soni, F Lei, SS Desale, LA Marky, SM Cohen, TK Bronich Journal of Controlled Release 264, 276-287, 2017 | 8 | 2017 |
| Challenges Meeting the CMC and Clinical Material Requirements During Gene Therapy Development KS Clare Blue, Linda Engle Biopharma Asia 11 (4), 2022 | | 2022 |
| Targeted Delivery of Drug Combinations Via Nanocarriers for Cancer Treatment KS Soni University of Nebraska Medical Center, 2017 | | 2017 |
